Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.08.005Source: DataRank Database

The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma is a research paper published in Journal of Thoracic Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 170 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access170 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 11.41)OA: greenTopics (29)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Francisco Sánchez-Vega ORCID,Kay See Tan ORCID,Brooke Mastrogiacomo ORCID,Jian Zhou ORCID,David R. Jones ORCID

Live enrichment

PubMed:32791233 PMC:PMC7704768 OpenAlex:https://openalex.org/W3048243382

U.S. Department of Defense

Grant: LC160212

National Cancer Institute

Grant: R01CA240472

National Cancer Institute

Grant: R01CA236615

National Cancer Institute

Grant: R01CA217169

National Cancer Institute

Grant: R01CA192399

National Institutes of Health

Grant: T32CA009501

National Institutes of Health

Grant: P30CA008748

NCATS NIH HHS

Grant: UL1 TR001863

Department of Surgery

National Cancer Research Institute

FWCI

11.41

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7704768

publisherhttps://api.elsevier.com/content/article/PII:S1556086420306365?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1556086420306365?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtho.2020.08.005

Fields of Study

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentLung Cancer Research Studies

MeSH Terms

Adenocarcinoma of LungAgedFemaleHumansLung NeoplasmsMaleMiddle AgedMutationNeoplasm Recurrence, LocalPrognosisGenomics

Keywords

MedicineAdenocarcinomaPathologyLungGenomicsCancerInternal medicineGenomeGeneGeneticsBiologyLung adenocarcinomaNext-generation SequencingHistologic SubtypesTumor Genomic Profiling

Sustainable Development Goals

SDG 0: Good health and well-being